Enhanced rapamycin delivery to hemangiomas by lipid polymer nanoparticles coupled with anti-VEGFR antibody.
Enhanced rapamycin delivery to hemangiomas by lipid polymer nanoparticles coupled with anti-VEGFR antibody.
Haitao Li,Yunfei Teng,Xia Xu,Jianyong Liu
2018 · DOI: 10.3892/ijmm.2018.3518
International Journal of Molecular Medicine · 18 Citations
TLDR
R‑PLNPs‑V could facilitate targeted delivery and sustained release of rapamycin to infantile hemangiomas, and thus may represent a promising candidate treatment for infantile Hemangeol.